Is illicit drug use harmful to cognitive functioning in the midadult years? A cohort-based investigation

American Journal of Epidemiology

Volumn 175, Issue 3, 2012, Pages 218-227

  Dregan, Alex ^a   Gulliford, Martin C ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

cognition; cohort studies; memory; prospective studies; street drugs

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE DERIVATIVE; AMYL NITRATE; CANNABIS; COCAINE; DIAMORPHINE; ILLICIT DRUG; KETAMINE; LYSERGIDE; METHADONE; PSYCHEDELIC AGENT; TEMAZEPAM;

ADULT; AGE STRUCTURE; COGNITION; COHORT ANALYSIS; DRUG USER; HEALTH RISK; HYPOTHESIS TESTING; MEMORY; PARTICIPATORY APPROACH; PUBLIC HEALTH;

ADULT; ARTICLE; COGNITION; CORRELATION ANALYSIS; DRUG ABUSE; DRUG DEPENDENCE; EXECUTIVE FUNCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MIDDLE AGED;

ADULT; COGNITION; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; STREET DRUGS;

EID: 84856202711     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr315     Document Type: Article

References (35)

1. Stephan MC, Brayne C. Vascular factors and prevention of dementia. Int Rev Psychiat. 2008;20(4):344-356.
2. Anstey KJ, Lipnicki DM, Low LF. Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry. 2008;16(5):343-354.
3. Feigin V, Ratnasabapathy Y, Anderson C. Does blood pressure lowering treatment prevents dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease? J Neurol Sci. 2005;229-230(1):151-155. (Pubitemid 40341579)
4. Ligthart SA, Moll van Charante EP, Van Gool WA, et al. Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review. Vasc Health Risk Manag. 2010;6(1):775-785.
5. Patel MD, Coshall C, Rudd AG, et al. Cognitive impairment after stroke: clinical determinants and its associations with long-term stroke outcomes. J Am Geriatr Soc. 2002;50(4): 700-706. (Pubitemid 34298758)
6. Fletcher JM, Page JB, Francis DJ, et al. Cognitive correlates of long-term cannabis use in Costa Rican men. Arch Gen Psychiatry. 1996;53(11):1051-1057. (Pubitemid 26384674)
7. Schilt T, deWin MM, Jager G, et al. Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users. Psychol Med. 2008;38(9):1309-1317.
8. Davis PE, Liddiard H, McMillan TM. Neuropsychological deficits and opiate abuse. Drug Alcohol Depend. 2002;67(1): 105-108. (Pubitemid 34615933)
9. Pope HG Jr, Ionescu-Pioggia M, Pope KW, et al. Drug use and life style among college undergraduates: a 30-year longitudinal study. Am J Psychiatry. 2001;158(9):1519-1521. (Pubitemid 32847258)
10. Kelley BJ, Yeager KR, Pepper TH, et al. Cognitive impairment in acute cocaine withdrawal. Cogn Behav Neurol. 2005;18(2): 108-112. (Pubitemid 40946423)
11. Lyketsos CG, Garrett E, Liang KY, et al. Cannabis use and cognitive decline in persons under 65 years of age. Am J Epidemiol. 1999;149(9):794-800. (Pubitemid 29196691)
12. Piechatzek M, Indlekofer F, Daamen M, et al. Is moderate substance use associated with altered executive functioning in a population-based sample of young adults? Hum Psychopharmacol. 2009;24(8):650-665.
13. Reneman L, Schilt T, deWin MM, et al. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users. J Psychopharmacol. 2006;20(3):389-399.
14. Yip JT, Lee TM. Effect of ecstasy use on neuropsychological function: a study in Hong Kong. Psychopharmacology (Berl). 2005;179(3):620-628. (Pubitemid 40674763)
15. Dregan A, Armstrong D. Adolescence sleep disturbances as predictors of adulthood sleep disturbances: a cohort study. J Adolesc Health. 2010;46(5):482-487.
16. Baars MA, van Boxtel MP, Dijkstra JB, et al. Predictive value of mild cognitive impairment for dementia: the influence of case definition and age. Dement Geriatr Cogn Disord. 2009; 27(2):173-181.
17. Marmot M, Banks J, Blundell R, et al. Health, Wealth and Lifestyles of the Older Population in England: The 2002 English Longitudinal Study of Ageing. London, United Kingdom: Institute for Fiscal Studies; 2003.
18. Herzog AR, Wallace RB. Measures of cognitive functioning in the AHEAD Study. J Gerontol B Psychol Sci Soc Sci. 1997; 52(suppl):37-48. (Pubitemid 27281898)
19. Ofstedal MB, Fisher GG, Herzog AR. HRS/AHEAD Documentation Report. Ann Arbor, MI: University of Michigan; 2005.
20. Nunn S, Cox K, Trinder J. ELSAWave 2-Derived Variables, Version 1: User Guide. London, United Kingdom: National Centre for Social Research, London; 2002.
21. Classification and Harmonisation Unit, United Kingdom Office for National Statistics. The National Statistics Socioeconomic Classification (NS-SEC Rebased on the SOC2010). London, United Kingdom: Office for National Statistics; 2010.
22. Mayfield D, McLeod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry. 1974;131(10):1121-1123.
23. Bynner J, Butler N, Ferri E, et al. The Design and Conduct of the 1999-2000 Surveys of the National Child Development Study and the 1970 British Birth Cohort Study: UK Data Archive. London, United Kingdom: Centre for Longitudinal Studies, Institute of Education; 2002.
24. White IR, Thompson SG. Adjusting for partially missing baseline measurements in randomized trials. Stat Med. 2005; 24(7):993-1007. (Pubitemid 40426000)
25. Rutter M, Tizard J, Whitmore K. Education, Health and Behaviour. London, United Kingdom: Longman; 1970.
26. Løberg EM, Hugdahl K. Cannabis use and cognition in schizophrenia. Front Hum Neurosci. 2009;3(1):53. (doi:10.3389/neuro.09.053.2009).
27. Underwood B, Fox K. A survey of alcohol and drug use among UK based dental undergraduates. Br Dent J. 2000; 189(6):314-317.
28. Fergusson DM, Boden JM, Horwood LJ. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction. 2006;101(4):556-569. (Pubitemid 43375619)
29. Joyal CC, Hallé P, Lapierre D, et al. Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia. Schizophr Res. 2003;63(3): 297-299. (Pubitemid 37101121)
30. Schnell T, Koethe D, Daumann J, et al. The role of cannabis in cognitive functioning of patients with schizophrenia. Psychopharmacology (Berl). 2009;205(1):45-52.
31. Yücel M, Bora E, Lubman DI, et al. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a firstepisode sample [published online ahead of print July 25, 2010]. Schizophr Bull. (doi:10.1093/schbul/sbq079).
32. Sevy S, Burdick KE, Visweswaraiah H, et al. Iowa gambling task in schizophrenia: a review and new data in patients with schizophrenia and co-occurring cannabis use disorders. Schizophr Res. 2007;92(1-3):74-84. (Pubitemid 46561220)
33. Indlekofer F, PiechatzekM, DaamenM, et al. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol. J Psychopharmacol. 2009;23(5):495-509.
34. Jones MP. Indicator and stratification methods for missing explanatory variables in multiple linear regression. J Am Stat Assoc. 1996;19(433):222-230. (Pubitemid 126353383)
35. RichardsM, Sacker A. Is education causal? Yes. Int J Epidemiol. 2011;40(2):516-518.